Innovation at every phase
In the fast-changing world of clinical trials, Philips Pharma Solutions stands by you at every phase of clinical research. We’re there to provide you with results based on facts and service delivered with a human touch.
Innovation at every phase
In the fast-changing world of clinical trials, Philips Pharma Solutions stands by you at every phase of clinical research. We’re there to provide you with results based on facts and service delivered with a human touch.
Informed by science. Backed by experience.
You need scientific expertise, breakthrough innovation, reliability and partnership in a clinical trials solution provider. Philips Pharma Solutions delivers just that. Our core lab for clinical trials offers you innovative solutions and technologies for cardiac safety monitoring and medical imaging. We offer support for complex, early-phase trials through to large-scale Phase 3 trials. We work alongside you to help streamline your approach to offsite and site-based clinical trials, so you can collect sound clinical endpoint data from anywhere and efficiently advance your trial with confidence.
Deep clinical trial and scientific expertise
Our team leverages more than 20 years of worldwide clinical trial experience across therapeutic areas, bringing rich and real-world perspectives to your pursuit of improving patients’ lives.
Powered for partnership
Our proactive team can help you anticipate and navigate challenges, taking a consultative partnership approach through every phase of research and development.
Enabling speed without compromising quality
The process of bringing a treatment to market to benefit the health and wellbeing of patients worldwide needs to be swift, safe, and secure. Philips Pharma Solutions Clinical Trial Optimization Platform is designed to be the next-generation tool for managing clinical endpoint data collection and analysis – developed to be scalable and flexible to meet the needs of even the most complex clinical studies, enabling speed and never compromising quality.
Offering innovative solutions and services at every stage
We provide centralized cardiac safety monitoring and medical imaging solutions for thousands of clinical trials worldwide, with expertise in all major therapeutic areas. You can be assured that whatever the scale or challenge, we can help you accomplish your goals.
Cardiac safety monitoring
Cardiac safety is a key component of any drug or device clinical trial. The FDA requires trial sponsors to demonstrate cardiac safety for all drugs. We can help to assure the safety of all your participants with our end-to-end services, including electrocardiography (ECG), event monitoring, blood pressure monitoring (BPM), long-term Holter monitoring, echocardiography (ECHO) and multi-gated acquisition scan (MUGA) studies. As part of one of the world’s largest cardiac data networks, we provide all major cardiovascular testing modalities and use state-of-the-art technology to transfer data efficiently and accurately to our secure central data center.
ECG
BPM
Event monitoring
Holter monitoring
ECHO/MUGA
Medical imaging
Our experienced professionals can help you see results from start to submission with a streamlined, secure process designed to minimize risk. Comprehensive medical imaging services for clinical trials include all major modalities for cardiovascular, oncological, musculoskeletal, metabolic and neurological diseases.
Cardiovascular
Oncology
Musculoskeletal
Metabolic diseases
Neurologic
Providing therapeutic expertise
A long-standing relationship with the FDA, EMA and other regulators, combined with our deep expertise across a wide range of therapeutic areas, can help support your research at every phase of development.
Cardiovascular
Including: atrial fibrillation, high blood pressure, arrhythmia, bradycardia, tachycardia and more
Immuno-oncology
Including: non-small cell lung cancer (NSCLC), breast cancer, lymphoma, colorectal cancer and more
Metabolic
Including: obesity, diabetes and more
Liver
Including: non-alcoholic steatohepatitis (NASH), non-alcoholic fatty liver disease (NAFLD), hepatocellular carcinoma and more
Musculoskeletal
Including: arthritis and more
Neurology
Including: Alzheimer’s disease, multiple sclerosis and more
An evolution in endpoint data collection and management
The efficiency and effectiveness of clinical trials depend greatly on the capabilities of the technology supporting them. It’s not enough to simply have the latest; your research requires a next-generation platform that evolves to meet your unique data collection and analysis needs. Clinical Trial Optimization Platform (CTOP) from Philips Pharma Solutions brings configurable advanced technology together with our skilled specialists, whose extensive expertise guides flexible, tailored services that can accelerate your timeline and protect your budget. Experience evolved endpoint data collection and management with CTOP.
From early to late phase, improve your trial’s data and process flow management with CTOP’s enrollment portal, reporting functionality, document repository, contracted deliverables and customized status reports and metrics. CTOP is configured to you, so every insight helps ensure your trial stays on track.
Experience faster study startup. Keep current with real-time data access. Maintain your momentum with proactive mitigation. At every phase of your research, get critical insights at CTOP speed.
Faster configuration
Discover the speed and scalability to meet the needs of even your most complex research with CTOP’s next-generation endpoint data collection and analysis. Our secure platform integrates cutting-edge AI and customized reporting to ensure you have high-quality analysis at your fingertips.
Real-time access
Gain real-time insight into your trial from anywhere with worldwide access to your data. With real-time access, CTOP ensures you’re an active part of your research no matter where you are while accelerating solutions that improve quality and maintain integrity.
Proactive mitigation
Scalable and flexible to meet the unique needs of every study, CTOP automatically identifies trends and assesses risk, enabling proactive mitigation, and since our efficient, adaptable system quickly accommodates protocol changes, needed adjustments happen in time to protect timelines and budgets.
